This coronary stent offers an innovative design, advanced technology, and best-in-class deliverability[i] XIENCE Sierra demonstrates flexibility and precision, enabling physicians to access and unblock difficult-to-treat blockages Abbott, the global healthcare company, announced the launch of XIENCE Sierra™ Everolimus (drug) Eluting Coronary Stent System in India.